Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV 16 L1 VLP vaccine in young females
NCT00365378Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 1999
- Primary completion
- Mar 2004
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of human papillomavirus type 16 L1 protein in Human Papillomavirus Type 16 Infection, sponsored by Merck & Co.. Started Sep 1999; status: completed.
02
Drugs
human papillomavirus type 16 L1 protein
03
Conditions
Human Papillomavirus Type 16 Infection
Beyond the preview
Go deeper on NCT00365378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365378.